A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer
Clinical trial NCT04311034 · COMPLETED
Trial details
- NCT number
- NCT04311034
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2021-12-21
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.